CFTR and ENaC functions in cystic fibrosis

被引:0
|
作者
Palma, Alejandra G. [1 ]
Kotsias, Basilio A. [1 ]
Marino, Gabriela I. [1 ]
机构
[1] Univ Buenos Aires, IDIM CONICET, Inst Invest Med Alfredo Lanari, Lab Cana Ion, Buenos Aires, DF, Argentina
关键词
cystic fibrosis; CFTR; ENaC; ionic movements; cytoskeleton; TRANSMEMBRANE CONDUCTANCE REGULATOR; GAP-JUNCTION CHANNELS; MUTATIONS; GENE; EXPRESSION; DELTA-F508; TRANSPORT; AMILORIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis is caused by dysfunction or lack of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that has a key role in maintaining ion and water honnoeostasis in different tissues. CFTR is a cyclic AMP-activated Cl- channel found in the apical and basal plasma membrane of airway, intestinal, and exocrine epithelial cells. One of CFTR's primary roles in the lungs is to maintain homoeostasis of the airway surface liquid layer through its function as a chloride channel and its regulation of the epithelial sodium channel ENaC. More than 1900 CFTR mutations have been identified in the cftr gene. The disease is characterized by viscous secretions of the exocrine glands in multiple organs and elevated levels of sweat sodium chloride. In cystic fibrosis, salt and fluid absorption is prevented by the loss of CFTR and ENaC is not appropriately regulated, resulting in increased fluid and sodium resorption from the airways and formation of a contracted viscous surface liquid layer. In the sweat glands both Na+ and Cl- ions are retained in the lumen, causing significant loss of electrolytes during sweating. Thus, elevated sweat NaCl concentration is the basis of the classic pilocarpine-induced sweat test as a diagnostic feature of the disease. Here we discuss the ion movement of Cl- and Na+ ions in two tissues, sweat glands and in the air surface as well as the role of ENaC in the pathogenesis of cystic fibrosis.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [41] CFTR Protein Repair Therapy in Cystic Fibrosis
    Quintana-Gallego, Esther
    Delgado-Pecellin, Isabel
    Calero Acuna, Carmen
    ARCHIVOS DE BRONCONEUMOLOGIA, 2014, 50 (04): : 146 - 150
  • [42] CFTR modulators: transformative therapies for cystic fibrosis
    Dwight, Mary
    Marshall, Bruce
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (02): : 281 - 284
  • [43] Triple CFTR Modulator Therapy for Cystic Fibrosis
    Holguin, Fernando
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (17): : 1671 - +
  • [44] Functional Consequences of CFTR Interactions in Cystic Fibrosis
    Ramananda, Yashaswini
    Naren, Anjaparavanda P.
    Arora, Kavisha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [45] CFTR modulation for young children with cystic fibrosis
    Yammine, Sophie
    Singer, Florian
    Latzin, Philipp
    LANCET RESPIRATORY MEDICINE, 2016, 4 (02): : 84 - 85
  • [46] Cystic Fibrosis and Oxidative Stress: The Role of CFTR
    Moliteo, Evelina
    Sciacca, Monica
    Palmeri, Antonino
    Papale, Maria
    Manti, Sara
    Parisi, Giuseppe Fabio
    Leonardi, Salvatore
    MOLECULES, 2022, 27 (16):
  • [47] CFTR, Mucins, and Mucus Obstruction in Cystic Fibrosis
    Kreda, Silvia M.
    Davis, C. William
    Rose, Mary Callaghan
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (09):
  • [48] CFTR, the chloride channel defective in cystic fibrosis
    Riordan, JR
    Kiser, GL
    Aleksandrov, AA
    Chang, XB
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R380 - R380